Cellular mechanisms of insulin resistance in humans (Q33694764)

28 July 2017

1 reference

title

Cellular mechanisms of insulin resistance in humans (English)

1 reference

28 July 2017

1 reference

1 reference

G I Shulman

1

1 reference

PubMed ID

10418851

28 July 2017

language of work or name

English

0 references

publication date

1 July 1999

1 reference

American Journal of Cardiology

28 July 2017

1 reference

28 July 2017

84

1 reference

28 July 2017

1A

1 reference

28 July 2017

3J-10J

1 reference

Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents.

28 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Beta-cell deficiency, insulin resistance, or both?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

31P nuclear magnetic resonance measurements of muscle glucose-6-phosphate. Evidence for reduced insulin-dependent muscle glucose transport or phosphorylation activity in non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Decreased muscle glucose transport/phosphorylation is an early defect in the pathogenesis of non-insulin-dependent diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Resistance to insulin but not to glucagon in lean human hypertriglyceridemics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

The glucose fatty acid cycle in obesity and maturity onset diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Mechanism of free fatty acid-induced insulin resistance in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Regulation of glucose uptake by muscle. 8. Effects of fatty acids, ketone bodies and pyruvate, and of alloxan-diabetes and starvation, on the uptake and metabolic fate of glucose in rat heart and diaphragm muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Mechanisms modifying glucose oxidation in diabetes mellitus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Metabolic effects of troglitazone monotherapy in type 2 diabetes mellitus. A randomized, double-blind, placebo-controlled trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

The impact of metformin therapy on hepatic glucose production and skeletal muscle glycogen synthase activity in overweight type II diabetic patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Acute antihyperglycemic mechanisms of metformin in NIDDM. Evidence for suppression of lipid oxidation and hepatic glucose production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

Efficacy and metabolic effects of metformin and troglitazone in type II diabetes mellitus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2899%2900350-1

10.1016/S0002-9149(99)00350-1

7 January 2021

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10418851